tDMARDs
DrugTraditional DMARDs for RA
NCT Number: NCT01438892
Several observational studies have evaluated the comparative treatment costs associated with each agent, particularly those within the anti-TNF class, but few have evaluated the impact of therapy compliance, persistence, treatment patterns on patient reported outcomes, healthcare utilization and costs, using a provider database. This study is designed to fill in this information gap.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cohort observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Traditional DMARDs for RA
Biologic DMARDs
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Pfizer
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00968266
Arthritis, Arthritis, Rheumatoid
Nijmegen, Netherlands
View Trial DetailsNCT02424877
Arthritis, Arthritis, Rheumatoid
Jyväskylä, Finland
View Trial DetailsNCT07491016
Arthritis, Arthritis, Rheumatoid
Hangzhou, Zhejiang, China
View Trial DetailsNCT06979271
Arthritis, Arthritis, Rheumatoid
Hangzhou, Zhejiang, China
View Trial Details